Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling.
Lee SG, Kim D, Lee JJ, Lee HJ, Moon RK, Lee YJ, Lee SJ, Lee OH, Kim C, Oh J, Lee CJ, Lee YH, Park S, Jeon OH, Choi D, Hong GR, Kim JS.
Lee SG, et al. Among authors: lee sj, lee cj, lee oh, lee yh, lee yj, lee jj, lee hj.
BMC Med. 2022 Sep 7;20(1):309. doi: 10.1186/s12916-022-02485-z.
BMC Med. 2022.
PMID: 36068525
Free PMC article.